Giuseppe Palmieri

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Sex and gender influence on adverse events for melanoma patients: a comprehensive review and meta-analysis

  British Journal of Cancer · 2025-11-22 · 2 citations

• How to treat BRAF mutant metastatic melanoma?

  Personalized Medicine · 2025-11-02

• 528 A novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution identified predictive spatial biomarkers in immunotherapy- and targeted therapy-treated melanoma patients

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis

  European Journal of Cancer · 2025-09-08 · 6 citations

• KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research

  Critical Reviews in Oncology/Hematology · 2025-09-05 · 3 citations

• EGFR Mutation Detection in Whole Slide Images of Non‐Small Cell Lung Cancers Using a Two‐Stage Deep Transfer Learning Approach

  Cancer Medicine · 2025-09-01 · 1 citations

• Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma

  Cancers · 2025-08-19 · 1 citations

• Cervical Lateral Mass and Pedicle Fracture Reduced with a Herbert Screw: A Technical Note

  Medical Sciences · 2025-07-19

• Genomic landscape of virus-associated cancers

  Nature Communications · 2025-07-01 · 3 citations

• Application of a novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution for predictive spatial biomarker identification on immunotherapy-treated melanoma patients.

  Journal of Clinical Oncology · 2025-05-28

• Sex and gender influence on adverse events for melanoma patients: A comprehensive review and meta-analysis.

  Journal of Clinical Oncology · 2025-05-28

• Serum thymidine kinase activity (TKa) as a potential biomarker in the sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma (SECOMBIT) trial.

  Journal of Clinical Oncology · 2025-05-28 · 2 citations

• Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity

  BioMetals · 2025-02-27 · 6 citations

• An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer

  Expert Review of Anticancer Therapy · 2024-12-01 · 2 citations

• Serine Esterases in Normal and Interleukin-2 Activated Rat NK Cells

  2024-11-12

• Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma

  NEJM Evidence · 2024-09-24 · 12 citations

• Genomic profiling by next-generation sequencing of idiopathic pulmonary fibrosis in Sardinia

  2024-09-14

• Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy

  Current Oncology · 2024-08-26 · 9 citations

• Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond

  Critical Reviews in Oncology/Hematology · 2024-07-06 · 28 citations